WaveMan
WaveMan · Company
IVPR · Inspire Veterinary Partners, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

IVPR Inspire Veterinary Partners (IVPR) Insider Trading, Ownership & Congress Trades

Agriculture · Agricultural services · CIK 0001939365
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter

Inspire Veterinary Partners insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for INSPIRE VETERINARY PARTNERS, INC. in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing

no insider purchases or sales on record

0 transactions on record
See all insider buying · insider selling
Showing the latest few. to use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
-0.5% year over year
more than 58% of all 58 companies we track
Margin
-86.0% net margin
below 84% of all 58 companies we track
Buybacks
no share repurchases reported
Short interest
19.9% of the float short (float per yahoo 2026-10-26) · 44.6 days to cover · settled 2026-09-30
the highest in all 58 companies we track
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch IVPR

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

Who owns IVPR: institutional holders (13F)

13F holdings, latest reported quarter
SEC 13F
No reported 13F holders

No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.

Congress trades in IVPR

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

IVPR planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
AVOLOCLPLNHLMNREDBLVFFALCOCALMGTBIFTSNDFCTVABV

IVPR financials

Revenue growth
-0.5%
XBRL, annual
Net margin
-86.0%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$15.6M
four quarters, 2024-10-01 to 2025-09-30
Net margin, TTM
-76.8%
net income over revenue, 2024-10-01 to 2025-09-30
Free cash flow, TTM
-$4.3M
operating cash flow minus capex, 2024-10-01 to 2025-09-30
Debt to equity
2.82x
long-term debt only, 2025-09-30; equity 2025-09-30
Cash flow to debt
-0.36x
TTM operating cash flow over long-term debt only, 2025-09-30
Return on equity
-331.8%
TTM net income over average of 2024-09-30 and 2025-09-30
Return on assets
-51.5%
TTM net income over average of 2024-09-30 and 2025-09-30
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on capital employed
-54.9%
operating income (EBIT proxy) over average of 2024-09-30 and 2025-09-30 minus current liabilities
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Enterprise value
n/a
no close on file at or before the as-of date
FCF yield
n/a
no close on file at or before the as-of date
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2024-122023-122022-12
Revenue$16.6M$16.7M$9.8M
Operating income-$9.0M-$7.2M-$3.5M
Net income-$14.3M-$14.8M-$4.9M
Operating cash flow-$10.0M-$3.8M-$2.7M
Cash$523.7K$179.0K$444.3K
Long-term debt$12.0Mn/a$3.7M
Buybacks$650.0Kn/an/a
SEC XBRL, fiscal years, as known on 2026-10-28

IVPR Stock Sonar score 4/7 axes

Find similar shapesCompare

IVPR ranks highest on growth (53rd percentile) and financial health (16th), and lowest on risk and compliance (1st), among Agriculture peers.

Profitability
13
Inputs
  • Return on equity-331.8% · 5 pct, universe of 3,863
  • Return on assets-51.5% · 18 pct, universe of 4,810
  • Return on invested capitaltax provision or pre-tax income not filed for the four quarters
  • Return on capital employed-54.9% · 18 pct, universe of 3,236
Financial health
16
Inputs
  • Debt to equity2.82x · 8 pct, universe of 3,589
  • Cash flow to debt-0.36x · 24 pct, universe of 3,315
Growth
53
Inputs
  • Revenue growth, YoY-0.5% · 53 pct, sector of 31
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Risk and compliance
0
Inputs
  • Short interest, % of float+19.9% · 0 pct, sector of 34
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Insider conviction, Institutional and government, US patents
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies